Form 4 for CVS CVS Health
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-03 · accession 0001127602-22-003406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-04 | 2022-02-03 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $102.26 | +47.9K | 186.2K | +35% | +$4.90M |
| D | 2022-02-04 | 2022-02-03 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale+OE | $110.00 | -47.9K | 138.2K | -26% | -$5.27M |
| D | 2022-02-04 | 2022-02-03 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $0.00 | -47.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-03 | M | A | 47,937 | $102.26 | 186,183.06 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-03 | S | D | 47,937 | $110.00 | 138,246.06 | D | — | — | |
| 3 | Derivative | Stock Option | 2022-02-03 | M | D | 47,937 | $0.00 | 0 | D | $102.26 · 2016-04-01 to 2022-04-01 | 47,937 Common Stock | (F2) Option became exercisable in four equal annual installments, commencing 4/1/2016. |